Development of Polyethylene Glycol-Sebacic Acid Diacrylate Microgels as a Drug Delivery System
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jinku | - |
dc.date.available | 2020-07-10T07:03:25Z | - |
dc.date.created | 2020-07-06 | - |
dc.date.issued | 2015-07 | - |
dc.identifier.issn | 0379-153X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/9682 | - |
dc.description.abstract | In this study, polyethylene glycol (PEG) based microgels were fabricated and evaluated their potential as a drug carrier. Polyethylene glycol sebacic acid diacrylate (PEGSDA) microgels were synthesized using emulsion polymerization and Texas red dextran (TRD) or bone morphogenetic protein-2 (BMP-2) was incorporated into the PEGSDA microgels. The drugs were homogeneously distributed throughout the PEGSDA microgels. TRD and BMP-2 release profiles from the microgels showed much less initial burst release compared to the PEGSDA bulk gels, thus it is possible to achieve sustained release of drugs of interest using the microgels. The bioactivities of BMP-2 released from the microgels were measured by proliferation and alkaline phosphatase (ALP) activity of W-20-17 (bone marrow stromal cell line) cells cultured in the presence of the released biomolecules. As a results, there were any detrimental effects on proliferation of the cells, and ALP activity of bone marrow stromal cells treated with BMP-2 released from PEGSDA microgels showed well maintained bioactivity of BMP-2. In addition, the bone marrow stromal cells were cultured on the surface of the microgels and the cells were well attached to the microgels, which shows another possible use of the microgels as a cell delivery system. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | POLYMER SOC KOREA | - |
dc.subject | BONE MORPHOGENETIC PROTEIN-2 | - |
dc.subject | TISSUE ENGINEERING SCAFFOLDS | - |
dc.subject | POLY(ETHYLENE GLYCOL) | - |
dc.subject | IN-VIVO | - |
dc.subject | HYDROGELS | - |
dc.subject | MACROMERS | - |
dc.subject | RHBMP-2 | - |
dc.subject | SURGERY | - |
dc.subject | SAFETY | - |
dc.title | Development of Polyethylene Glycol-Sebacic Acid Diacrylate Microgels as a Drug Delivery System | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jinku | - |
dc.identifier.doi | 10.7317/pk.2015.39.4.677 | - |
dc.identifier.scopusid | 2-s2.0-84940206288 | - |
dc.identifier.wosid | 000358818500022 | - |
dc.identifier.bibliographicCitation | POLYMER-KOREA, v.39, no.4, pp.677 - 682 | - |
dc.relation.isPartOf | POLYMER-KOREA | - |
dc.citation.title | POLYMER-KOREA | - |
dc.citation.volume | 39 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 677 | - |
dc.citation.endPage | 682 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002013562 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Polymer Science | - |
dc.relation.journalWebOfScienceCategory | Polymer Science | - |
dc.subject.keywordPlus | BONE MORPHOGENETIC PROTEIN-2 | - |
dc.subject.keywordPlus | TISSUE ENGINEERING SCAFFOLDS | - |
dc.subject.keywordPlus | POLY(ETHYLENE GLYCOL) | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | HYDROGELS | - |
dc.subject.keywordPlus | MACROMERS | - |
dc.subject.keywordPlus | RHBMP-2 | - |
dc.subject.keywordPlus | SURGERY | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordAuthor | PEG based microgel | - |
dc.subject.keywordAuthor | tissue engineering | - |
dc.subject.keywordAuthor | regenerative medicine | - |
dc.subject.keywordAuthor | drug delivery system | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
94, Wausan-ro, Mapo-gu, Seoul, 04066, Korea02-320-1314
COPYRIGHT 2020 HONGIK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.